Key Findings:  The results suggest that the CB2 receptor agonists might be clinically useful as an adjunct treatment against seizure spread and status epilepticus and concomitant oxidative stress, neurotoxicity and cognitive impairments.
Type of Study:  Animal Study
Study Result:  Positive
Study Location(s):  Brazil, Bulgaria
Year of Pub:  2018
Cannabinoids Studied: 
Phytocannabinoid Source:  Not Applicable
Terpenes Studied:  ß-Caryophyllene
Receptors Studied:  CB2